MIST Ultrasound Therapy Compared to United Kingdom Standard Care for the Treatment of Non-healing… (NCT01671748) | Clinical Trial Compass
CompletedNot Applicable
MIST Ultrasound Therapy Compared to United Kingdom Standard Care for the Treatment of Non-healing Venous Leg Ulcers
United Kingdom47 participantsStarted 2012-08
Plain-language summary
Chronic venous leg ulcers (VLUs) impact negatively on patients' quality of life. Standard treatment in the UK for patients with VLUs is compression bandaging or stockings. The MIST ultrasound system is a noncontact device which delivers low frequency ultrasound through a gentle saline mist directed at a patient's wound. This study aims to determine whether the use of the MIST device used in combination with standard treatments can improve healing of VLUs compared to UK standard practice. This will be assessed by measuring any reduction in wound size in the two groups after receiving 8 weeks of either Standard Care once a week or MIST combined with Standard Care three times a week.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Venous leg ulcers (as diagnosed by the clinician)
* Ankle Brachial Pressure Index (ABPI) \>0.8
* If multiple ulcers are present treat largest ulcer only (index ulcer) with minimum distance of 1 cm between index ulcer and any other ulcer
* 18 years or older
* Ulcer size of 5 cm\^2 - 100 cm\^2 (with no longest length being greater than 10 cm) at randomisation point (week 5)
* Mobile enough to attend clinic
* Index ulcer between 6 weeks and 5 years duration prior to screening date
Exclusion Criteria:
* Uncontrolled diabetes (Hba1c ≥12%) as tested within the past 3 months
* Index ulcer has active infection on day of inclusion requiring use or oral or IV antibiotics
* Renal failure
* Index ulcer has exposed tendons, ligaments, muscle, or bone
* Osteomyelitis or cellulitis or gangrene in study limb
* Subjects with amputation above a trans metatarsal amputation (TMA) in the study limb
* Subjects with active malignancy on the study limb
* Index ulcer that is of arterial disease aetiology
* Females of child bearing potential who are not willing to use a method of highly effective contraception during the entire study
* Planned vascular surgery, angioplasty, or thrombolysis procedures within the study period, or 6 weeks post-operatively
* Planned surgical procedure during the study period for the index wound
* Prior skin replacement, negative pressure therapy, ultrasound therapy applied to the index wound 2 weeks before screening
* Oral or IV antibiotics within…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.